BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35579877)

  • 1. Chromosome 1 instability in multiple myeloma: Aberrant gene expression, pathogenesis, and potential therapeutic target.
    Luo S; Su T; Zhou X; Hu WX; Hu J
    FASEB J; 2022 Jun; 36(6):e22341. PubMed ID: 35579877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosome 1 abnormalities in multiple myeloma.
    Marzin Y; Jamet D; Douet-Guilbert N; Morel F; Le Bris MJ; Morice P; Abgrall JF; Berthou C; De Braekeleer M
    Anticancer Res; 2006; 26(2A):953-9. PubMed ID: 16619492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome 1q21 abnormalities in multiple myeloma.
    Schmidt TM; Fonseca R; Usmani SZ
    Blood Cancer J; 2021 Apr; 11(4):83. PubMed ID: 33927196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An acquired high-risk chromosome instability phenotype in multiple myeloma: Jumping 1q Syndrome.
    Sawyer JR; Tian E; Walker BA; Wardell C; Lukacs JL; Sammartino G; Bailey C; Schinke CD; Thanendrarajan S; Davies FE; Morgan GJ; Barlogie B; Zangari M; van Rhee F
    Blood Cancer J; 2019 Aug; 9(8):62. PubMed ID: 31399558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormalities of chromosome 1p/q are highly associated with chromosome 13/13q deletions and are an adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma.
    Wu KL; Beverloo B; Lokhorst HM; Segeren CM; van der Holt B; Steijaert MM; Westveer PH; Poddighe PJ; Verhoef GE; Sonneveld P; ;
    Br J Haematol; 2007 Feb; 136(4):615-23. PubMed ID: 17223915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Throughput Copy Number Profiling by Digital Multiplex Ligation-Dependent Probe Amplification in Multiple Myeloma.
    Kosztolányi S; Kiss R; Atanesyan L; Gángó A; de Groot K; Steenkamer M; Jáksó P; Matolcsy A; Kajtár B; Pajor L; Szuhai K; Savola S; Bödör C; Alpár D
    J Mol Diagn; 2018 Nov; 20(6):777-788. PubMed ID: 30096382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescence in situ hybridization reveals the evolutionary biology of minor clone of gain/amp(1q) in multiple myeloma.
    Cui J; Liu Y; Lv R; Yan W; Xu J; Li L; Du C; Yu T; Zhang S; Deng S; Sui W; Hao M; Yi S; Zou D; Qiu L; Xu Y; An G
    Leukemia; 2024 Jun; 38(6):1299-1306. PubMed ID: 38609496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gain of chromosome arm 1q in patients in relapse and progression of multiple myeloma.
    Balcárková J; Urbánková H; Scudla V; Holzerová M; Bacovský J; Indrák K; Jarosová M
    Cancer Genet Cytogenet; 2009 Jul; 192(2):68-72. PubMed ID: 19596256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative PCR: an alternative approach to detect common copy number alterations in multiple myeloma.
    Chillón MC; Jiménez C; García-Sanz R; Alcoceba M; Prieto I; García-Alvarez M; Antón A; Maldonado R; Hernández-Ruano M; González M; Gutiérrez NC; Sarasquete ME
    Ann Hematol; 2017 Oct; 96(10):1699-1705. PubMed ID: 28770277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome instability in multiple myeloma.
    Neuse CJ; Lomas OC; Schliemann C; Shen YJ; Manier S; Bustoros M; Ghobrial IM
    Leukemia; 2020 Nov; 34(11):2887-2897. PubMed ID: 32651540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of Multiple Myeloma with Chromosome 1q Gain and 1p Deletion after Autologous Hematopoietic Stem Cell Transplantation: Propensity Score Matched Analysis.
    Varma A; Sui D; Milton DR; Tang G; Saini N; Hasan O; Mukherjee A; Joseph JJ; Bashir Q; Rondon G; Srour S; Popat UR; Hosing CM; Nieto Y; Kebriaei P; Alousi AM; Ahmed S; Mehta R; Khouri IF; Ahmed H; Iyer S; Weber DM; Thomas SK; Manasanch E; Lee HC; Patel K; Ciurea SO; Shpall EJ; Orlowski RZ; Champlin RE; Qazilbash MH
    Biol Blood Marrow Transplant; 2020 Apr; 26(4):665-671. PubMed ID: 31881283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value.
    Walker BA; Leone PE; Chiecchio L; Dickens NJ; Jenner MW; Boyd KD; Johnson DC; Gonzalez D; Dagrada GP; Protheroe RK; Konn ZJ; Stockley DM; Gregory WM; Davies FE; Ross FM; Morgan GJ
    Blood; 2010 Oct; 116(15):e56-65. PubMed ID: 20616218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q.
    Orsetti B; Nugoli M; Cervera N; Lasorsa L; Chuchana P; Rougé C; Ursule L; Nguyen C; Bibeau F; Rodriguez C; Theillet C
    Br J Cancer; 2006 Nov; 95(10):1439-47. PubMed ID: 17060936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic aberrations in anaplastic multiple myeloma: high frequency of 1q21(CKS1B) amplifications.
    Bahmanyar M; Qi X; Chang H
    Leuk Res; 2013 Dec; 37(12):1726-8. PubMed ID: 24169086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis, clinical characteristics and personalized managements of multiple myeloma with chromosome 1 abnormalities.
    Zhou P; Li W; Zuo S; Ma R; Yuan X; Zhu Z
    Leuk Lymphoma; 2023; 64(8):1373-1388. PubMed ID: 37300424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering the chronology of copy number alterations in Multiple Myeloma.
    Aktas Samur A; Minvielle S; Shammas M; Fulciniti M; Magrangeas F; Richardson PG; Moreau P; Attal M; Anderson KC; Parmigiani G; Avet-Loiseau H; Munshi NC; Samur MK
    Blood Cancer J; 2019 Mar; 9(4):39. PubMed ID: 30914633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic instability in multiple myeloma: evidence for jumping segmental duplications of chromosome arm 1q.
    Sawyer JR; Tricot G; Lukacs JL; Binz RL; Tian E; Barlogie B; Shaughnessy J
    Genes Chromosomes Cancer; 2005 Jan; 42(1):95-106. PubMed ID: 15472896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of an epigenetic origin for high-risk 1q21 copy number aberrations in multiple myeloma.
    Sawyer JR; Tian E; Heuck CJ; Johann DJ; Epstein J; Swanson CM; Lukacs JL; Binz RL; Johnson M; Sammartino G; Zangari M; Davies FE; van Rhee F; Morgan GJ; Barlogie B
    Blood; 2015 Jun; 125(24):3756-9. PubMed ID: 25943786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular cytogenetic analyses of patients with plasma cell myeloma in Tolna and Baranya counties in Hungary].
    Kosztolányi S; Horváth B; Hosnyánszki D; Kereskai L; Sziládi E; Jáksó P; Alizadeh H; Szuhai K; Alpár D; Kajtár B
    Orv Hetil; 2019 Jun; 160(24):944-951. PubMed ID: 31433233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation between chromosome 13q14 deletion and 1q abnormality in multiple myeloma].
    Chen LJ; Li JY; Zhu Y; Wang XW; Qiu HR; Yang RF; Xu W; Xu JR; Lu H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Feb; 26(1):102-5. PubMed ID: 19199264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.